HuGE Literature Finder
Records 1-30
|
Molecular profiling and molecular classification of endometrioid ovarian carcinomas.
Gynecologic oncology 2019 Jul . Cybulska Paulina, Paula Arnaud Da Cruz, Tseng Jill, Leitao Mario M, Bashashati Ali, Huntsman David G, Nazeran Tayyebeh M, Aghajanian Carol, Abu-Rustum Nadeem R, DeLair Deborah F, Shah Sohrab P, Weigelt Brit |
|
Single nucleotide polymorphism of PIK3CA and its interaction with the environment are risk factors for Chinese Han ovarian cancer.
Pathology, research and practice 2019 Jun 152520. Zhang Hui, Zhou |
|
Loss of 1p36.33 Frequent in Low-Grade Serous Ovarian Cancer.
Neoplasia (New York, N.Y.) 2019 May 21 (6): 582-590. Van Nieuwenhuysen Els, Busschaert Pieter, Laenen Annouschka, Moerman Philippe, Han Sileny N, Neven Patrick, Lambrechts Diether, Vergote Igna |
|
RAS Mutation in Mucinous Carcinoma of the Ovary
Asian Pacific journal of cancer prevention : APJCP 2019 Apr 20 (4): 1127-1132. Panyavaranant Pinyada, Teerapakpinyo Chinachote, Pohthipornthawat Natkrita, Oranratanaphan Shina, Shuangshoti Shanop, Triratanachat Sura |
|
Pilot investigation of the mutation profile of PIK3CA/PTEN genes (PI3K pathway) in grade 3 endometrial cancer.
Oncology reports 2019 Mar 41 (3): 1560-1574. Malentacchi Francesca, Turrini Irene, Sorbi Flavia, Projetto Elisabetta, Castiglione Francesca, Fambrini Massimiliano, Petraglia Felice, Pillozzi Serena, Noci I |
|
Targeted sequencing of a specific gene panel detects a high frequency of ARID1A and PIK3CA mutations in ovarian clear cell carcinoma.
Clinica chimica acta; international journal of clinical chemistry 2019 Mar 494 1-7. Su Yu-Fa, Tsai Eing-Mei, Chen Chih-Chieh, Wu Chun-Chieh, Er Tze-Kio |
|
The genetic landscape of 87 ovarian germ cell tumors.
Gynecologic oncology 2018 Aug . Van Nieuwenhuysen Els, Busschaert Pieter, Neven Patrick, Han Sileny N, Moerman Philippe, Liontos Michalis, Papaspirou Maria, Kupryjanczyk Jolanta, Hogdall Claus, Hogdall Estrid, Oaknin Ana, Garcia Angel, Mahner Sven, Trillsch Fabian, Cibula David, Heitz Florian, Concin Nicole, Speiser Paul, Salvesen Helga, Sehouli Jalid, Lambrechts Diether, Vergote Igna |
|
Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in Japanese patients.
Oncotarget 2018 Mar 9 (19): 14754-14763. Ishikawa Masako, Nakayama Kentaro, Nakamura Kohei, Ono Ruriko, Sanuki Kaori, Yamashita Hitomi, Ishibashi Tomoka, Minamoto Toshiko, Iida Kouji, Razia Sultana, Ishikawa Noriyoshi, Kyo Sato |
|
Mutational Aberrations Detected in Mucinous Epithelial Ovarian Cancer of Asian Women.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2018 Mar 28 (3): 428-436. Chay Wen Yee, Kwok Li Lian, Tiong Wen Ning, Krisna Sai Sakktee, Lim Kiat Hon, Iyer N Gopalkrishna, Goh Liang Kee, Tan Daniel Shao-We |
|
Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer.
Acta oncologica (Stockholm, Sweden) 2018 Jan 1-6. Christensen Troels Dreier, Palshof Jesper Andreas, Larsen Finn Ole, Poulsen Tim Svenstrup, Høgdall Estrid, Pfeiffer Per, Jensen Benny Vittrup, Yilmaz Mette Karen, Nielsen Dor |
|
Genomic landscape of ovarian clear cell carcinoma via whole exome sequencing.
Gynecologic oncology 2018 02 148 (2): 375-382. Kim Se Ik, Lee Ji Won, Lee Maria, Kim Hee Seung, Chung Hyun Hoon, Kim Jae-Weon, Park Noh Hyun, Song Yong-Sang, Seo Jeong-S |
|
Identification of somatic genetic alterations in ovarian clear cell carcinoma with next generation sequencing.
Genes, chromosomes & cancer 2018 02 57 (2): 51-60. Shibuya Yusuke, Tokunaga Hideki, Saito Sakae, Shimokawa Kazurou, Katsuoka Fumiki, Bin Li, Kojima Kaname, Nagasaki Masao, Yamamoto Masayuki, Yaegashi Nobuo, Yasuda J |
|
Mutational heterogeneity in non-serous ovarian cancers.
Scientific reports 2017 Aug 7 (1): 9728. Teer Jamie K, Yoder Sean, Gjyshi Anxhela, Nicosia Santo V, Zhang Chaomei, Monteiro Alvaro N |
|
Genotype-matched treatment for patients with advanced type I epithelial ovarian cancer (EOC).
Gynecologic oncology 2017 Jan . Spreafico A, Oza A M, Clarke B A, Mackay H J, Shaw P, Butler M, Dhani N C, Lheureux S, Wilson M K, Welch S, Zhang T, Yu C, Stockley T, Siu L L, Kamel-Reid S, Bedard P |
|
CCNE1 copy-number gain and overexpression identify ovarian clear cell carcinoma with a poor prognosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2016 Oct . Ayhan Ayse, Kuhn Elisabetta, Wu Ren-Chin, Ogawa Hiroshi, Bahadirli-Talbott Asli, Mao Tsui-Lien, Sugimura Haruhiko, Shih Ie-Ming, Wang Tian- |
|
Discordant Mutations in Paired Primary and Metastatic Endometrial Adenocarcinomas Identified by Semiconductor-Based Sequencing for Rapid Cancer Genotyping.
Reproductive sciences (Thousand Oaks, Calif.) 2016 May . Bergstrom Colin P, Geest Koen De, O'Gara Rebecca, Corless Christopher L, Morgan Terry |
|
Molecular Profiling of Clear Cell Ovarian Cancers: Identifying Potential Treatment Targets for Clinical Trials.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2016 May 26 (4): 648-54. Friedlander Michael L, Russell Kenneth, Millis Sherri, Gatalica Zoran, Bender Ryan, Voss Andre |
|
PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients.
Molecular oncology 2015 Oct 9 (8): 1694-703. Westin Shannon N, Ju Zhenlin, Broaddus Russell R, Krakstad Camilla, Li Jane, Pal Navdeep, Lu Karen H, Coleman Robert L, Hennessy Bryan T, Klempner Samuel J, Werner Henrica M J, Salvesen Helga B, Cantley Lewis C, Mills Gordon B, Myers Andrea |
|
Somatic mutations in breast and serous ovarian cancer young patients: a systematic review and meta-analysis.
Revista da Associac?a?o Me?dica Brasileira (1992) 2015 Oct 61 (5): 474-83. Encinas Giselly, Maistro Simone, Pasini Fátima Solange, Katayama Maria Lucia Hirata, Brentani Maria Mitzi, Bock Geertruida Hendrika de, Folgueira Maria Aparecida Azevedo Koi |
|
Endometrial Carcinomas With Clear Cells: A Study of a Heterogeneous Group of Tumors Including Interobserver Variability, Mutation Analysis, and Immunohistochemistry With HNF-1?.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists 2015 Jul 34 (4): 323-33. Han Guangming, Soslow Robert A, Wethington Stephanie, Levine Douglas A, Bogomolniy Faina, Clement Philip B, Köbel Martin, Gilks Blake, DeLair Debor |
|
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2015 Jul 26 (7): 1363-71. Beltrame L, Di Marino M, Fruscio R, Calura E, Chapman B, Clivio L, Sina F, Mele C, Iatropoulos P, Grassi T, Fotia V, Romualdi C, Martini P, Noris M, Paracchini L, Craparotta I, Petrillo M, Milani R, Perego P, Ravaggi A, Zambelli A, Ronchetti E, D'Incalci M, Marchini |
|
Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing.
International journal of oncology 2015 Jun 46 (6): 2389-98. Takenaka Masataka, Saito Motonobu, Iwakawa Reika, Yanaihara Nozomu, Saito Misato, Kato Mamoru, Ichikawa Hitoshi, Shibata Tatsuhiro, Yokota Jun, Okamoto Aikou, Kohno Takas |
|
Molecular analysis of isolated tumor glands from endometrial endometrioid adenocarcinomas.
Pathology international 2015 May 65 (5): 240-9. Suga Yasuko, Sugai Tamotsu, Uesugi Noriyuki, Kawasaki Tomonori, Fukagawa Tomoyuki, Yamamoto Eiichiro, Ishida Kazuyuki, Suzuki Hiromu, Sugiyama To |
|
Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas.
PloS one 2015 10 (6): e0128066. Uehara Yuriko, Oda Katsutoshi, Ikeda Yuji, Koso Takahiro, Tsuji Shingo, Yamamoto Shogo, Asada Kayo, Sone Kenbun, Kurikawa Reiko, Makii Chinami, Hagiwara Otoe, Tanikawa Michihiro, Maeda Daichi, Hasegawa Kosei, Nakagawa Shunsuke, Wada-Hiraike Osamu, Kawana Kei, Fukayama Masashi, Fujiwara Keiichi, Yano Tetsu, Osuga Yutaka, Fujii Tomoyuki, Aburatani Hiroyu |
|
Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
BMC cancer 2015 15 (1): 415. Mackenzie Robertson, Kommoss Stefan, Winterhoff Boris J, Kipp Benjamin R, Garcia Joaquin J, Voss Jesse, Halling Kevin, Karnezis Anthony, Senz Janine, Yang Winnie, Prigge Elena-Sophie, Reuschenbach Miriam, Doeberitz Magnus Von Knebel, Gilks Blake C, Huntsman David G, Bakkum-Gamez Jamie, McAlpine Jessica N, Anglesio Michael |
|
Chromosome 20q13.2 ZNF217 locus amplification correlates with decreased E-cadherin expression in ovarian clear cell carcinoma with PI3K-Akt pathway alterations.
Human pathology 2014 Nov 45 (11): 2318-25. Huang Hsien-Neng, Huang Wen-Chih, Lin Ching-Hung, Chiang Ying-Cheng, Huang Hsin-Ying, Kuo Kuan-Ti |
|
Assessing PIK3CA and PTEN in early-phase trials with PI3K/AKT/mTOR inhibitors.
Cell reports 2014 Jan 6 (2): 377-87. Janku Filip, Hong David S, Fu Siqing, Piha-Paul Sarina A, Naing Aung, Falchook Gerald S, Tsimberidou Apostolia M, Stepanek Vanda M, Moulder Stacy L, Lee J Jack, Luthra Rajyalakshmi, Zinner Ralph G, Broaddus Russell R, Wheler Jennifer J, Kurzrock Razel |
|
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 Jan 27 (1): 128-34. McConechy Melissa K, Ding Jiarui, Senz Janine, Yang Winnie, Melnyk Nataliya, Tone Alicia A, Prentice Leah M, Wiegand Kimberly C, McAlpine Jessica N, Shah Sohrab P, Lee Cheng-Han, Goodfellow Paul J, Gilks C Blake, Huntsman David |
|
Distinct molecular profiles in Lynch syndrome-associated and sporadic ovarian carcinomas.
International journal of cancer. Journal international du cancer 2013 Dec 133 (11): 2596-608. Niskakoski Anni, Kaur Sippy, Renkonen-Sinisalo Laura, Lassus Heini, Järvinen Heikki J, Mecklin Jukka-Pekka, Bützow Ralf, Peltomäki Päi |
|
PIK3CA Gene Mutations and Amplifications in Chinese Patients With Ovarian Clear Cell Carcinoma.
Cancer investigation 2013 Dec 31 (10): 10. Jiang G, Huang Z, Zhang S, Wang L |
|
PIK3CA missense mutation is associated with unfavorable outcome in grade 3 endometrioid carcinoma but not in serous endometrial carcinoma.
Gynecologic oncology 2013 Nov . McIntyre JB, Nelson GS, Ghatage P, Morris D, Duggan MA, Lee CH, Doll CM, Köbel M |
|
High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma.
Gynecologic oncology 2013 Feb 128 (2): 327-34. Garcia-Dios Diego A, Lambrechts Diether, Coenegrachts Lieve, Vandenput Ingrid, Capoen An, Webb Penelope M, Ferguson Kaltin, , Akslen Lars A, Claes Bart, Vergote Ignace, Moerman Philippe, Van Robays Johan, Marcickiewicz Janusz, Salvesen Helga B, Spurdle Amanda B, Amant Frédér |
|
Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma.
Human pathology 2012 Dec 43 (12): 2197-206. Rahman Munmun, Nakayama Kentaro, Rahman Mohammed Tanjimur, Nakayama Naomi, Ishikawa Masako, Katagiri Atsuko, Iida Kouji, Nakayama Satoru, Otsuki Yoshiro, Shih Ie-Ming, Miyazaki Koh |
|
Frequency of mutations and polymorphisms in borderline ovarian tumors of known cancer genes.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 Nov . Stemke-Hale K, Shipman K, Kitsou-Mylona I, de Castro DG, Hird V, Brown R, Flanagan J, Gabra H, Mills GB, Agarwal R, El-Bahrawy M |
|
Use of mutation profiles to refine the classification of endometrial carcinomas.
The Journal of pathology 2012 Sep 228 (1): 20-30. McConechy Melissa K, Ding Jiarui, Cheang Maggie C U, Wiegand Kimberly C, Senz Janine, Tone Alicia A, Yang Winnie, Prentice Leah M, Tse Kane, Zeng Thomas, McDonald Helen, Schmidt Amy P, Mutch David G, McAlpine Jessica N, Hirst Martin, Shah Sohrab P, Lee Cheng-Han, Goodfellow Paul J, Gilks C Blake, Huntsman David |
|
PIK3CA mutations in endometrial carcinomas in Chinese women: phosphatidylinositol 3'-kinase pathway alterations might be associated with favorable prognosis.
Human pathology 2012 Aug 43 (8): 1197-205. Dong Ying, Yang Xi, Wong Oscar, Zhang Xiaoming, Liang Ying, Zhang Ying, Wong Wei, Nong Lin, Liao Qinping, Li Ti |
|
Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 Apr 25 (4): 615-24. Yamamoto Sohei, Tsuda Hitoshi, Takano Masashi, Tamai Seiichi, Matsubara Osa |
|
PI3K/AKT/mTOR inhibitors in patients with breast and gynecologic malignancies harboring PIK3CA mutations.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 Mar 30 (8): 777-82. Janku Filip, Wheler Jennifer J, Westin Shannon N, Moulder Stacy L, Naing Aung, Tsimberidou Apostolia M, Fu Siqing, Falchook Gerald S, Hong David S, Garrido-Laguna Ignacio, Luthra Rajyalakshmi, Lee J Jack, Lu Karen H, Kurzrock Razel |
|
PIK3CA mutations and amplification in endometrioid endometrial carcinomas: relation to other genetic defects and clinicopathologic status of the tumors.
Human pathology 2011 Nov 42 (11): 1710-9. Konopka Bo?ena, Janiec-Jankowska Aneta, Kwiatkowska Ewa, Najmo?a Urszula, Bidzi?ski Mariusz, Olszewski W?odzimierz, Goluda Cypri |
|
PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma.
Virchows Archiv : an international journal of pathology 2011 Nov . Yamamoto S, Tsuda H, Takano M, Tamai S, Matsubara O |
|
PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma.
The Journal of pathology 2011 Oct 225 (2): 189-94. Yamamoto Sohei, Tsuda Hitoshi, Takano Masashi, Iwaya Keichi, Tamai Seiichi, Matsubara Osa |
|
Assessment of hepatocyte growth factor in ovarian cancer mortality.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2011 Aug 20 (8): 1638-48. Goode Ellen L, Chenevix-Trench Georgia, Hartmann Lynn C, Fridley Brooke L, Kalli Kimberly R, Vierkant Robert A, Larson Melissa C, White Kristin L, Keeney Gary L, Oberg Trynda N, Cunningham Julie M, Beesley Jonathan, Johnatty Sharon E, Chen Xiaoqing, Goodman Katelyn E, Armasu Sebastian M, Rider David N, Sicotte Hugues, Schmidt Michele M, Elliott Elaine A, Høgdall Estrid, Kjær Susanne Krüger, Fasching Peter A, Ekici Arif B, Lambrechts Diether, Despierre Evelyn, Høgdall Claus, Lundvall Lene, Karlan Beth Y, Gross Jenny, Brown Robert, Chien Jeremy, Duggan David J, Tsai Ya-Yu, Phelan Catherine M, Kelemen Linda E, Peethambaram Prema P, Schildkraut Joellen M, Shridhar Vijayalakshmi, Sutphen Rebecca, Couch Fergus J, Sellers Thomas A, |
|
Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer.
British journal of cancer 2009 Mar 100 (6): 993-1001. Quaye L, Song H, Ramus S J, Gentry-Maharaj A, Høgdall E, DiCioccio R A, McGuire V, Wu A H, Van Den Berg D J, Pike M C, Wozniak E, Doherty J A, Rossing M A, Ness R B, Moysich K B, Høgdall C, Blaakaer J, , Easton D F, Ponder B A J, Jacobs I J, Menon U, Whittemore A S, Krüger-Kjaer S, Pearce C L, Pharoah P D P, Gayther S |
|
PIK3CA amplification associates with resistance to chemotherapy in ovarian cancer patients.
Cancer biology & therapy 2009 Jan 8 (1): 21-6. Kolasa Iwona K, Rembiszewska Alina, Felisiak Anna, Ziolkowska-Seta Izabela, Murawska Magdalena, Moes Joanna, Timorek Agnieszka, Dansonka-Mieszkowska Agnieszka, Kupryjanczyk Jolan |
|
Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008 Dec 17 (12): 3567-72. Palmieri Rachel T, Wilson Melanie A, Iversen Edwin S, Clyde Merlise A, Calingaert Brian, Moorman Patricia G, Poole Charles, Anderson A Rebecca, Anderson Stephanie, Anton-Culver Hoda, Beesley Jonathan, Hogdall Estrid, Brewster Wendy, Carney Michael E, Chen Xiaoqing, Chenevix-Trench Georgia, Chang-Claude Jenny, Cunningham Julie M, Dicioccio Richard A, Doherty Jennifer A, Easton Douglas F, Edlund Christopher K, Gayther Simon A, Gentry-Maharaj Aleksandra, Goode Ellen L, Goodman Marc T, Kjaer Susanne Kruger, Hogdall Claus K, Hopkins Michael P, Jenison Eric L, Blaakaer Jan, Lurie Galina, McGuire Valerie, Menon Usha, Moysich Kirsten B, Ness Roberta B, Pearce Celeste Leigh, Pharoah Paul D P, Pike Malcolm C, Ramus Susan J, Rossing Mary Anne, Song Honglin, Terada Keith Y, Vandenberg David, Vierkant Robert A, Wang-Gohrke Shan, Webb Penelope M, Whittemore Alice S, Wu Anna H, Ziogas Argyrios, Berchuck Andrew, Schildkraut Joellen M, , , |
|
The effects of common genetic variants in oncogenes on ovarian cancer survival.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Sep 14 (18): 5833-9. Quaye Lydia, Gayther Simon A, Ramus Susan J, Di Cioccio Richard A, McGuire Valerie, Hogdall Estrid, Hogdall Claus, Blaakr Jan, Easton Douglas F, Ponder Bruce A J, Jacobs Ian, Kjaer Susanne Kruger, Whittemore Alice S, Pearce Celeste Leigh, Pharoah Paul D P, Song Hongl |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 23, 2020
- Content source: